Perceptive Advisors as of Dec. 31, 2013
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 106 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 10.3 | $86M | 509k | 168.96 | |
| Sarepta Therapeutics (SRPT) | 10.1 | $84M | 4.1M | 20.37 | |
| Acelrx Pharmaceuticals | 8.9 | $74M | 6.6M | 11.31 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.2 | $60M | 812k | 74.30 | |
| Tesaro | 4.9 | $41M | 1.4M | 28.24 | |
| Neurocrine Biosciences (NBIX) | 4.7 | $39M | 4.2M | 9.34 | |
| Aegerion Pharmaceuticals | 3.8 | $32M | 448k | 70.96 | |
| Covidien | 3.1 | $26M | 375k | 68.10 | |
| EXACT Sciences Corporation (EXAS) | 2.8 | $23M | 2.0M | 11.69 | |
| MannKind Corporation | 2.4 | $20M | 3.8M | 5.21 | |
| Macrogenics (MGNX) | 2.4 | $20M | 718k | 27.43 | |
| Walgreen Company | 2.2 | $19M | 322k | 57.44 | |
| Abbvie (ABBV) | 2.2 | $19M | 350k | 52.81 | |
| Dyax | 2.1 | $18M | 2.3M | 7.53 | |
| Neptune Technologies Bioreso | 2.0 | $17M | 5.9M | 2.90 | |
| Mylan | 2.0 | $17M | 393k | 43.40 | |
| Xencor (XNCR) | 1.7 | $14M | 1.6M | 9.14 | |
| Incyte Corporation (INCY) | 1.6 | $14M | 269k | 50.63 | |
| Endocyte | 1.4 | $12M | 1.1M | 10.69 | |
| Biogen Idec (BIIB) | 1.3 | $11M | 40k | 279.75 | |
| CIGNA Corporation | 1.3 | $11M | 125k | 87.48 | |
| Spectranetics Corporation | 1.0 | $8.7M | 346k | 25.00 | |
| Relypsa | 1.0 | $8.5M | 341k | 25.00 | |
| Anacor Pharmaceuticals | 1.0 | $8.2M | 488k | 16.78 | |
| Health Net | 1.0 | $8.1M | 273k | 29.67 | |
| HeartWare International | 1.0 | $8.0M | 85k | 93.96 | |
| Chelsea Therapeutics International | 0.9 | $7.5M | 1.7M | 4.43 | |
| Retrophin | 0.9 | $7.4M | 1.1M | 7.00 | |
| Cell Therapeutics | 0.8 | $7.1M | 3.7M | 1.92 | |
| Gentium S.p.A. | 0.8 | $6.9M | 120k | 57.10 | |
| CVS Caremark Corporation (CVS) | 0.8 | $6.4M | 89k | 71.57 | |
| Zeltiq Aesthetics | 0.7 | $5.8M | 306k | 18.91 | |
| Arno Therapeutics | 0.7 | $5.7M | 2.0M | 2.80 | |
| Taro Pharmaceutical Industries (TARO) | 0.7 | $5.6M | 57k | 98.90 | |
| Aerie Pharmaceuticals | 0.7 | $5.4M | 300k | 17.96 | |
| Acasti Pharma | 0.6 | $5.2M | 4.4M | 1.19 | |
| Capital Senior Living Corporation | 0.6 | $5.0M | 209k | 23.99 | |
| Infinity Pharmaceuticals (INFIQ) | 0.6 | $4.8M | 350k | 13.81 | |
| Athersys | 0.5 | $4.3M | 1.7M | 2.50 | |
| Alliqua | 0.5 | $4.0M | 558k | 7.25 | |
| Gilead Sciences (GILD) | 0.5 | $3.8M | 50k | 75.16 | |
| Tandem Diabetes Care | 0.4 | $3.2M | 126k | 25.77 | |
| Verastem | 0.3 | $2.5M | 220k | 11.44 | |
| Ophthotech | 0.3 | $2.4M | 75k | 32.35 | |
| Repligen Corporation (RGEN) | 0.3 | $2.3M | 165k | 13.64 | |
| Zogenix | 0.3 | $2.2M | 650k | 3.44 | |
| Mgc Diagnostics | 0.3 | $2.3M | 180k | 12.66 | |
| Chimerix (CMRX) | 0.3 | $2.3M | 150k | 15.08 | |
| Five Prime Therapeutics | 0.3 | $2.2M | 133k | 16.79 | |
| Auxilium Pharmaceuticals | 0.2 | $2.1M | 100k | 20.74 | |
| Champions Oncology | 0.2 | $2.0M | 1.6M | 1.20 | |
| Zimmer Holdings (ZBH) | 0.2 | $1.9M | 20k | 93.20 | |
| Clovis Oncology | 0.2 | $1.8M | 31k | 60.26 | |
| Idenix Pharmaceuticals | 0.2 | $1.8M | 300k | 5.98 | |
| Neostem | 0.2 | $1.6M | 230k | 6.82 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $1.5M | 198k | 7.60 | |
| Shire | 0.2 | $1.4M | 10k | 141.30 | |
| Santarus | 0.2 | $1.5M | 45k | 31.96 | |
| Repros Therapeutics | 0.2 | $1.3M | 72k | 18.29 | |
| Anthera Pharmaceutcls | 0.2 | $1.3M | 432k | 3.07 | |
| Dex (DXCM) | 0.1 | $1.1M | 30k | 35.40 | |
| Curis | 0.1 | $987k | 350k | 2.82 | |
| Transgenomic | 0.1 | $993k | 2.2M | 0.45 | |
| Vivus | 0.1 | $908k | 100k | 9.08 | |
| Oncothyreon | 0.1 | $880k | 500k | 1.76 | |
| Uroplasty | 0.1 | $857k | 314k | 2.73 | |
| MiMedx (MDXG) | 0.1 | $874k | 100k | 8.74 | |
| United Therapeutics Corporation (UTHR) | 0.1 | $792k | 7.0k | 113.14 | |
| Orexigen Therapeutics Inc note 2.750%12/0 | 0.1 | $735k | 750k | 0.98 | |
| Nanosphere | 0.1 | $676k | 295k | 2.29 | |
| Surgical Care Affiliates | 0.1 | $697k | 20k | 34.85 | |
| Hologic (HOLX) | 0.1 | $559k | 25k | 22.36 | |
| Newcastle Investment | 0.1 | $402k | 70k | 5.74 | |
| Bluebird Bio (BLUE) | 0.1 | $420k | 20k | 21.00 | |
| athenahealth | 0.0 | $336k | 2.5k | 134.40 | |
| INSTRS INC Stemcells | 0.0 | $334k | 272k | 1.23 | |
| Medgenics | 0.0 | $367k | 61k | 5.99 | |
| XenoPort | 0.0 | $288k | 50k | 5.76 | |
| Lannett Company | 0.0 | $223k | 6.7k | 33.07 | |
| Illumina (ILMN) | 0.0 | $221k | 2.0k | 110.50 | |
| Myriad Genetics (MYGN) | 0.0 | $210k | 10k | 21.00 | |
| Cutera (CUTR) | 0.0 | $228k | 22k | 10.18 | |
| Medidata Solutions | 0.0 | $220k | 3.6k | 60.41 | |
| Insys Therapeutics | 0.0 | $221k | 5.7k | 38.62 | |
| DaVita (DVA) | 0.0 | $151k | 2.4k | 63.39 | |
| Omnicare | 0.0 | $150k | 2.5k | 60.19 | |
| Impax Laboratories | 0.0 | $150k | 6.0k | 25.16 | |
| Alere | 0.0 | $149k | 4.1k | 36.10 | |
| Hill-Rom Holdings | 0.0 | $152k | 3.7k | 41.23 | |
| Centene Corporation (CNC) | 0.0 | $154k | 2.6k | 59.00 | |
| Pain Therapeutics | 0.0 | $172k | 36k | 4.84 | |
| Analogic Corp Com Stk | 0.0 | $146k | 1.6k | 88.81 | |
| Astrazeneca | 0.0 | $152k | 2.6k | 59.42 | |
| Tornier Nv | 0.0 | $188k | 10k | 18.80 | |
| Neoprobe | 0.0 | $207k | 100k | 2.07 | |
| Express Scripts Holding | 0.0 | $146k | 2.1k | 70.19 | |
| Affymetrix | 0.0 | $73k | 8.5k | 8.55 | |
| Endo Pharmaceuticals | 0.0 | $77k | 1.1k | 67.66 | |
| Rite Aid Corporation | 0.0 | $76k | 15k | 5.09 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $78k | 2.0k | 38.42 | |
| Puma Biotechnology (PBYI) | 0.0 | $76k | 735.00 | 103.40 | |
| Geron Corporation (GERN) | 0.0 | $22k | 4.7k | 4.70 | |
| Immunomedics | 0.0 | $13k | 2.9k | 4.56 | |
| Axogen (AXGN) | 0.0 | $20k | 4.5k | 4.44 | |
| Combimatrix Corporation *w exp 05/01/ | 0.0 | $3.0k | 5.0k | 0.60 | |
| D Stemline Therapeutics | 0.0 | $1.0k | 38.00 | 26.32 |
